CDKN2A and heart failure: Moreover, the abundance of the senescence marker cyclin‐dependent kinase inhibitor 2A (CDKN2A, best known as p16), which has been causatively involved in DOX‐induced cardiac failure (Demaria et al., 2017), was reduced by ACBP neutralization (Figure 6k).